Free DNA in cystic fibrosis airway fluids correlates with airflow obstruction

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Marcos, Veronica ^a   Zhou Suckow, Zhe ^b   Önder Yildirim, Ali ^c   Bohla, Alexander ^c   Hector, Andreas ^a,d   Vitkov, Ljubomir ^e,f   Krautgartner, Wolf Dietrich ^f   Stoiber, Walter ^f   Griese, Matthias ^a   Eickelberg, Oliver ^c   Mall, Marcus A ^b   Hartl, Dominik ^a,d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

^f UNIVERSITY OF SALZBURG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; DNA; F ACTIN; INTERLEUKIN 8; LIGAND;

ADULT; AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ARTICLE; ASPERGILLUS FUMIGATUS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DNA STRAND; DNA STRUCTURE; EXTRACELLULAR TRAP; FEMALE; FUNGAL COLONIZATION; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; WILD TYPE; ADOLESCENT; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; C3H MOUSE; C57BL MOUSE; CHEMISTRY; CHILD; CYSTIC FIBROSIS; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; YOUNG ADULT;

MUS;

ADOLESCENT; ADULT; AIRWAY OBSTRUCTION; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES, CXC; CHILD; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; DNA; FEMALE; HUMANS; INFLAMMATION; LIGANDS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEUTROPHILS; PSEUDOMONAS AERUGINOSA; YOUNG ADULT;

EID: 84928255176     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/408935     Document Type: Article

References (66)

1. M. A. Mall and D. Hartl, "CFTR: cystic fibrosis and beyond," European Respiratory Journal, vol. 44,no. 4, pp. 1042-1054, 2014.
2. E. Fantino, C. L. Gangell, D. Hartl, P. D. Sly, and C. F. Arest, "Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease," BMC Pulmonary Medicine, vol. 14, article 28, 2014.
3. P. D. Sly, C. L. Gangell, L. Chen et al., "Risk factors for bronchiectasis in children with cystic fibrosis,"TheNewEngland Journal of Medicine, vol. 368, no. 21, pp. 1963-1970, 2013.
4. D. Hartl, A. Gaggar, E. Bruscia et al., "Innate immunity in cystic fibrosis lung disease," Journal of Cystic Fibrosis, vol. 11, no. 5, pp. 363-382, 2012.
5. S. D. Sagel,M. K. Sontag, J. S. Wagener,R. K. Kapsner, I. Osberg, and F. J. Accurso, "Induced sputuminflammatory measures correlate with lung function in children with cystic fibrosis," Journal of Pediatrics, vol. 141, no. 6, pp. 811-817, 2002.
6. S. D. Sagel, R. Kapsner, I. Osberg, M. K. Sontag, and F. J. Accurso, "Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction," The American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 8 I, pp. 1425-1431, 2001.
7. A. Hector, M. S. D. Kormann, I. Mack et al., "The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease," PLoS ONE, vol. 6, no. 9,Article ID e24399, 2011.
8. S. Gehrig, J. Duerr,M. Weitnauer et al., "Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but notmucus obstruction, in micewith cystic fibrosislike lung disease," American Journal of Respiratory and Critical Care Medicine, vol. 189, no. 9, pp. 1082-1092, 2014.
9. K. K. Kirchner, J. S. Wagener, T. Z. Khan, S. C. Copenhaver, and F. J. Accurso, "Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis," American Journal of Respiratory and Critical CareMedicine, vol. 154, no. 5, pp. 1426-1429, 1996.
10. V. Papayannopoulos, D. Staab, and A. Zychlinsky, "Neutrophil elastase enhances sputumsolubilization in cystic fibrosis patients receiving dnase therapy," PLoS ONE, vol. 6, no. 12, Article ID e28526, 2011.
11. R. L. Young, K. C. Malcolm, J. E. Kret et al., "Neutrophil extracellular trap (NET)-mediated killing of pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR," PLoS ONE, vol. 6, no. 9, Article ID e23637, 2011.
12. M. Dwyer, Q. Shan, S. D'Ortona et al., "Cystic fibrosis sputum DNA Has NETosis characteristics and neutrophil extracellular trap release is regulated by macrophage migration-inhibitory factor," Journal of Innate Immunity, vol. 6, no. 6, pp. 765-779, 2014.
13. D.-G. Yoo, M. Floyd, M. Winn, S. M. Moskowitz, and B. Rada, "NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes," Immunology Letters, vol. 160, no. 2, pp. 186-194, 2014.
14. R. Manzenreiter, F. Kienberger,V. Marcos et al., "Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy," Journal of Cystic Fibrosis, vol. 11, no. 2, pp. 84-92, 2012.
15. V. Brinkmann, U. Reichard, C. Goosmann et al., "Neutrophil extracellular traps kill bacteria," Science, vol. 303, no. 5663, pp. 1532-1535, 2004.
16. V. Brinkmann and A. Zychlinsky, "Beneficial suicide: why neutrophils die to make NETs," Nature Reviews Microbiology, vol. 5, no. 8, pp. 577-582, 2007.
17. T. A. Fuchs, U. Abed, C. Goosmann et al., "Novel cell death program leads to neutrophil extracellular traps," The Journal of Cell Biology, vol. 176, no. 2, pp. 231-241, 2007.
18. S. Yousefi, J. A. Gold,N. Andina et al., "Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense," Nature Medicine, vol. 14, no. 9, pp. 949-953, 2008.
19. S. Yousefi,D. Simon, and H.-U. Simon, "Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease," CurrentOpinion in Immunology, vol. 24,no. 6, pp. 736-737, 2012.
20. S. Yousefi, C. Mihalache, E. Kozlowski, I. Schmid, and H. U. Simon, "Viable neutrophils releasemitochondrial DNA to form neutrophil extracellular traps," Cell Death&Differentiation, vol. 16, no. 11, pp. 1438-1444, 2009.
21. D. Simon, H.-U. Simon, and S. Yousefi, "Extracellular DNA traps in allergic, infectious, and autoimmune diseases," Allergy, vol. 68, no. 4, pp. 409-416, 2013.
22. M. Morshed, R. Hlushchuk, D. Simon et al., "NADPH oxidase-independent formation of extracellular DNA traps by basophils," The Journal of Immunology, vol. 192, no. 11, pp. 5314-5323, 2014.
23. R. Dworski, H.-U. Simon, A. Hoskins, and S. Yousefi, "Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways," Journal of Allergy and Clinical Immunology, vol. 127, no. 5, pp. 1260-1266, 2011.
24. A. Peschel and D. Hartl, "Anuclear neutrophils keep hunting," Nature Medicine, vol. 18, no. 9, pp. 1336-1338, 2012.
25. B. G. Yipp, B. Petri, D. Salina et al., "DynamicNETosis is carried out by live neutrophils in human and mouse bacterial abscesses and during severe gram-positive infection," Nature Medicine, vol. 6, no. 20, 2012.
26. M. Mall, B. R. Grubb, J. R. Harkema, W. K. O'Neal, and R. C. Boucher, "Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice," Nature Medicine, vol. 10, no. 5, pp. 487-493, 2004.
27. Z. Zhou, J. Duerr, B. Johannesson et al., "The ENaCoverexpressing mouse as a model of cystic fibrosis lung disease," Journal of Cystic Fibrosis, vol. 10, supplement 2, pp. S172-S182, 2011.
28. M. A. Mall, S. Y. Graeber, M. Stahl, and Z. Zhou-Suckow, "Early cystic fibrosis lung disease: Role of airway surface dehydration and lessons frompreventive rehydration therapies in mice," The International Journal of Biochemistry & Cell Biology, vol. 52, pp. 174-179, 2014.
29. M. A. Mall, J. R. Harkema, J. B. Trojanek et al., "Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice," The American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 7, pp. 730-742, 2008.
30. T. W. R. Lee, K. G. Brownlee, S. P. Conway, M. Denton, and J. M. Littlewood, "Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients," Journal of Cystic Fibrosis, vol. 2, no. 1, pp. 29-34, 2003.
31. D. Hartl, V. Starosta, K. Maier et al., "Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs," Free Radical Biology andMedicine, vol. 39,no. 4, pp. 463-472, 2005.
32. D. Hartl, P. Latzin, P. Hordijk et al., "Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease," Nature Medicine, vol. 13, no. 12, pp. 1423-1430, 2007.
33. J. A. J. Vanoirbeek,M. Rinaldi,V. DeVooght et al., "Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases," The American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 1, pp. 96-104, 2010.
34. M. A. Mall, B. Button, B. Johannesson et al., "Airway surface liquid volume regulation determines different airway phenotypes in liddle compared with ENaC-overexpressing mice," Journal of Biological Chemistry, vol. 285, no. 35, pp. 26945-26955, 2010.
35. M. Saffarzadeh, C. Juenemann, M. A. Queisser et al., "Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones," PLoS ONE, vol. 7, no. 2,Article ID e32366, 2012.
36. V. Papayannopoulos and A. Zychlinsky, "NETs: a new strategy for using old weapons," Trends in Immunology, vol. 30, no. 11, pp. 513-521, 2009.
37. A. Zychlinsky, "Neutrophil extracellular traps," European Journal of Clinical Investigation, vol. 39, p. 27, 2009.
38. M. Zawrotniak and M. Rapala-Kozik, "Neutrophil extracellular traps (NETs)-formation and implications," Acta Biochimica Polonica, vol. 60, no. 3, pp. 277-284, 2013.
39. B. G. Yipp and P. Kubes, "NETosis: how vital is it" Blood, vol. 122, no. 16, pp. 2784-2794, 2013.
40. O. Z. Cheng and N. Palaniyar, "NET balancing: a problem in inflammatory lung diseases," Frontiers in Immunology, vol. 4, article 1, 2013.
41. T. A. Fuchs, A. Brill, and D. D. Wagner, "Neutrophil extracellular trap (NET) impact on deep vein thrombosis," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 8, pp. 1777-1783, 2012.
42. M.-L. von Brühl, K. Stark, A. Steinhart et al., "Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo," Journal of Experimental Medicine, vol. 209, no. 4, pp. 819-835, 2012.
43. S. Rahman and M. Gadjeva, "Does NETosis contribute to the bacterial pathoadaptation in cystic fibrosis" Frontiers in Immunology, vol. 5, article 378, 2014.
44. P. A. Flume, B. P. O'Sullivan, K. A. Robinson et al., "Cystic fibrosis pulmonary guidelines: chronic medications formaintenance of lung health," American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 10, pp. 957-969, 2007.
45. G. Döring, P. Flume, H. Heijerman, and J. S. Elborn, "Treatment of lung infection in patients with cystic fibrosis: current and future strategies," Journal of Cystic Fibrosis, vol. 11,no. 6, pp. 461-479, 2012.
46. P. A. Flume and D. R. vanDevanter, "State of progress in treating cystic fibrosis respiratory disease,"BMCMedicine, vol. 10, article 88, 2012.
47. Q. Shan, M. Dwyer, S. Rahman, and M. Gadjeva, "Distinct susceptibilities of corneal Pseudomonas aeruginosa clinical isolates to neutrophil extracellular trap-mediated immunity," Infection and Immunity, vol. 82, no. 10, pp. 4135-4143, 2014.
48. D. G. Yoo, M. Winn, L. Pang et al., "Release of cystic fibrosis airway inflammatory markers from pseudomonas aeruginosastimulated human neutrophils involves NADPH oxidasedependent extracellular DNA trap formation," Journal of Immunology, vol. 192, no. 10, pp. 4728-4738, 2014.
49. B. Rada, M. A. Jendrysik, L. Pang et al., "Pyocyanin-enhanced neutrophil extracellular trap formation requires the NADPH oxidase," PLoS ONE, vol. 8, no. 1,Article ID e54205, 2013.
50. N. Branzk, A. Lubojemska, S. E. Hardison et al., "Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens," Nature Immunology, vol. 15, no. 11, pp. 1017-1025, 2014.
51. O. E. Sørensen, S. N. Clemmensen, S. L. Dahl et al., "Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses," The Journal of Clinical Investigation, vol. 124, no. 10, pp. 4539-4548, 2014.
52. K. D. Metzler, C. Goosmann, A. Lubojemska,A. Zychlinsky, and V. Papayannopoulos, "A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis," Cell Reports, vol. 8, no. 3, pp. 883-896, 2014.
53. N. Branzk and V. Papayannopoulos, "Molecular mechanisms regulating NETosis in infection and disease," Seminars in Immunopathology, vol. 35, no. 4, pp. 513-530, 2013.
54. V. Papayannopoulos, K. D. Metzler, A. Hakkim, and A. Zychlinsky, "Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps," The Journal of Cell Biology, vol. 191, no. 3, pp. 677-691, 2010.
55. A. V. Dubois, A. Gauthier,D. Bréa et al., "Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum," American Journal of Respiratory Cell and Molecular Biology, vol. 47, no. 1, pp. 80-86, 2012.
56. M. Griese, M. Kappler, A. Gaggar, and D. Hartl, "Inhibition of airway proteases in cystic fibrosis lung disease," European Respiratory Journal, vol. 32, no. 3, pp. 783-795, 2008.
57. F. Carswell,D. W. Robinson,C. C. L. Ward, and M. R. Waterfield, "Deoxyribonucleic acid output in the sputum from cystic fibrosis patients," European Journal of Respiratory Diseases, vol. 65, no. 1, pp. 53-57, 1984.
58. J.-S. Kim, K. Okamoto, and B. K. Rubin, "Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis," Chest, vol. 129, no. 5, pp. 1148-1154, 2006.
59. D. N. Douda, R. Jackson, H. Grasemann, and N. Palaniyar, "Innate immune collectin surfactant protein D simultaneously binds both neutrophil extracellular traps and carbohydrate ligands and promotes bacterial trapping," The Journal of Immunology, vol. 187, no. 4, pp. 1856-1865, 2011.
60. P. E. Bratcher, N. M. Weathington, H. J. Nick, P. L. Jackson, R. J. Snelgrove, and A. Gaggar, "MMP-9 cleaves SP-D and abrogates its innate immune functions in vitro," PLoS ONE, vol. 7, no. 7, Article ID e41881, 2012.
61. H. V. Olesen, U. Holmskov, P. O. Schiøtz, and G. L. Sørensen, "Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis," Journal of Cystic Fibrosis, vol. 9, no. 4, pp. 257-262, 2010.
62. J. Cooley, B. McDonald, F. J. Accurso, E. C. Crouch, and E. Remold-O'Donnell, "Patterns of neutrophil serine proteasedependent cleavage of surfactant protein D in inflammatory lung disease," Journal of Leukocyte Biology, vol. 83, no. 4, pp. 946-955, 2008.
63. D. Hartl and M. Griese, "Surfactant protein D in human lung diseases," European Journal of Clinical Investigation, vol. 36, no. 6, pp. 423-435, 2006.
64. C. von Bredow, A. Wiesener, and M. Griese, "Proteolysis of surfactant protein D by cystic fibrosis relevant proteases," Lung, vol. 181, no. 2, pp. 79-88, 2003.
65. F. H. Pilsczek, D. Salina, K. K. H. Poon et al., "A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus," Journal of Immunology, vol. 185, no. 12, pp. 7413-7425, 2010.
66. M. Saffarzadeh and K. T. Preissner, "Fighting against the dark side of neutrophil extracellular traps in disease:manoeuvres for host protection," Current Opinion in Hematology, vol. 20, no. 1, pp. 3-9, 2013.